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IL-1b mediates host immunity through its ability to influence both innate and adaptive immune responses. It promotes innate immunity by inducing the acute phase response and recruiting inflammatory cells [1] [2] [3] [4] . In the adaptive immune system, IL-1b enhances T cell priming and differentiation 5 , and more importantly acts as a licensing cytokine to enable memory CD4 T cell effector function 6 . However, aberrant production of IL-1b in the absence of pathogenic insult can result in immunopathology associated with several auto-immune and autoinflammatory diseases 7 . In fact, IL-1b blockade has been proven to be a successful treatment for several autoimmune conditions including psoriasis, rheumatoid arthritis (RA), and uveitis 8 . Autoinflammatory disorders can be a consequence of gain-of-function mutations in inflammasome machinery which results in spontaneous IL-1b production [9] [10] [11] [12] [13] . Due to this association, IL-1b production in these disorders is often attributed to inflammasome activation 14 . In the case of T cell driven auto-immunity, where IL-1b is implicated as a major driver of pathology, the role of inflammasome in IL-1b production remains obsure [14] [15] [16] [17] . GWAS studies have also failed to report significant genetic association between inflammasome proteins and T cell dependent autoimmunity 14 . Additionally, disease progression in mouse models of RA was found to be independent of the inflammasome components NLRP3 and caspase-1 16 . Similarly, caspase-1 deficiency did not mitigate diabetes in NOD mice 18 . Together, this prompted us to investigate how bioactive IL-1b is produced during T cell-driven autoimmune diseases in the absence of overt infection or injury.
We have previously demonstrated that T cell intrinsic IL-1R signaling is critical for optimal cytokine production by effector and memory CD4 T cells following their reactivation using DCs 6 . The DCs used in these experiments were not stimulated by any microbial ligands, thus leading us to hypothesize that cognate interaction between DCs and effector CD4 T cells might elicit the production of bioactive IL1b independent of pattern recognition receptor (PRR) signaling. Indeed, cognate interaction of DCs with effector CD4 T cells led to secretion of IL-1b in the absence of innate immune sensing (Fig. 1a) . Furthermore, we found that DC interaction with effector CD4 T cells of Th1, Th2 and Th17 lineages all led to secretion of IL-1b, pointing to a broadly conserved pathway of IL-1b production (Fig. 1b) . Since all CD4 T cell lineages were found to instruct IL-1b production by DCs, we henceforth use Th0 cells to represent effector CD4 T cells, unless otherwise noted. These initial experiments were performed using anti-TCR antibody stimulation that activates T cells regardless of their specificity. We therefore examined if this IL-1b production was in fact dependent on presentation of cognate peptide by DCs. When OVA peptide-restricted OT-II TCR transgenic effector T cells were reactivated using DCs, IL-1b production was strictly dependent on the presence of the cognate OVA323-339 peptide (Fig. 1c) . More interestingly, the quantity of IL-1b found in the supernatants directly correlated with the concentration of the stimulating peptide (Fig. 1d) , indicating that the avidity of MHC-TCR interaction is a major determinant of the amount of IL-1b being secreted. While it has been reported that CD4 T cells can produce IL-1b 19 , we found that DCs were the only source of IL-1b during their interaction with effector CD4 T cells (Fig. 1e) .
Production of IL-1b relies on two independent signals: a priming signal necessary for transcription and synthesis of proIL-1b, followed by a cleavage signal required for its biological activity 20 . We observed that DC-T cell interaction led to rapid transcriptional upregulation of Il1b (Fig. 1f) . This experiment was performed using Il1b -/-T cells to ensure analysis of Il1b transcript specifically in DCs. The transcriptional induction translated into accumulation of intracellular pro-IL-1b (Fig.  1g) . In addition to proIL-1b synthesis, interaction with effector CD4 T cells also induced cleavage of pro-IL-1b into its bioactive 17kDa fragment (Fig. 1h) , which could be detected in the supernatant. These data demonstrate that interaction of DCs with effector CD4 T cells can trigger transcriptional induction of pro-IL-1b as well as its bioactive cleavage.
Next, we decided to characterize the signaling events that enable this IL-1b production. Inflammasome activation is a major mechanism by which IL-1b is produced 21 . The priming signal during inflammasome activation is provided by sensing of microbial ligands by pattern recognition receptors (PRRs) such as TLRs that culminates into NF-kB activation and transcriptional upregulation of pro-IL1b 22 . Since DCs used in these experiments were not exposed to any microbial ligands, we posited that a PRR-independent signal is likely to be involved in proIL1b synthesis. A significant difference in the magnitude of pro-IL-1b synthesis following TLR stimulation as compared to T cell interaction also suggested a TLR independent mechanism (Fig 1g) . Nevertheless, to rule out the contribution of inadvertent endotoxin contamination in these in vitro cultures, we analyzed induction of proIL-1b in Tlr2/4 -/-as well as Myd88 -/-DCs. We found no defect in effector CD4 T cell driven IL-1b induction in DCs deficient for TLR signaling (Fig  2a and Supplementary Fig. 1a and 1b) . It is well known that pro-IL-1b transcription is mediated by NFkB 22 and AP-1 23 , which can also be activated downstream of receptors for the TNF superfamily. This prompted us to examine a potential role for these receptors in pro-IL-1b synthesis in the absence of microbial recognition by DCs. We directly tested the role of TNFR superfamily signaling in IL-1b production by neutralizing individual ligands during DC-T cell interaction. We found that neutralization of TNFa and FasL, but not CD40L, significantly compromised IL-1b production (Fig. 2b) . This suggested that TNFR as well as Fas signaling participate in PRR independent IL-1b production by DCs. Upon careful examination, we observed that the pro-IL-1b levels were compromised only in the absence of TNFa (Fig. 2c) , while Fas signaling was dispensable for pro-IL-1b synthesis (Fig. 2c) . This result suggests that while Fas-FasL interaction is critical for bioactive IL-1b production, it is not required for the transcriptional induction of pro-IL-1b. Consistently, intracellular pro-IL-1b was also significantly reduced upon neutralization of TNFa (Fig. 2d) . Moreover, stimulation of DCs with recombinant TNFa was sufficient to drive the synthesis of pro-IL-1b ( Supplementary Fig. 1c ). Since TNFa neutralization does not result in complete abrogation of pro-IL-1b, additional pathways could contribute to pro-IL-1b synthesis that require further investigation. The existence of diversified mechanisms of T cell induced pro-IL1b, is parallel to the ability of several innate recognition receptors to upregulate IL1b 21, 24, 25 . We found that effector CD4 T cells of all lineages (Th1, Th2 and Th17) rapidly upregulate TNFa following their interaction with DCs ( Supplementary Fig.  1d ). While TNFa is primarily known to be an effector cytokine of the Th17 lineage 26 , we found that primed Th1 and Th2 lineage cells are also capable of producing TNFa ( Supplementary Fig. 1d ), suggesting that activated CD4 T cells of all lineages are poised to engage TNFR on DCs. It is important to note that while TNFa is known to be largely of myeloid origin in PAMP driven inflammation, activated T cells seem to be the predominant TNFa producers during their interactions with DCs ( Fig. 2e and Supplementary Fig. 1e ). Consistent with this finding, TNFa deficient T cells induced significantly diminished pro-IL-1b (Fig 2f) production by DCs. Finally, combined deficiency of TNFR1 and TNFR2 on DCs showed that DC intrinsic TNFR signaling was required for optimal IL-1b production ( Fig. 2g ).
We then proceeded to identify the molecular mechanism responsible for proteolytic cleavage of pro-IL-1b. Caspase-1, the effector protease of all inflammasomes 27 , is largely responsible for bioactive cleavage of pro-IL-1b 14 . Indeed, we found that the aspartate residue in pro-IL-1b, where caspase-1 cleaves, is critical for IL-1b production following DC-T cell interaction ( Supplementary Fig. 2a) . Surprisingly, we did not detect active caspase-1 following DC-T cell interaction (Fig. 3a) . Furthermore, we found that genetic ablation of caspase-1 in DCs did not compromise IL-1b release ( Fig. 3b and Supplementary Fig. 2b ). These data point to the existence of an inflammasome independent mechanism of IL-1b production that is employed by DCs during their interaction with effector CD4 T cells. In the experiments above, we found that blocking Fas-FasL interaction led to a complete loss of detectable IL-1b in the supernatants, without affecting the synthesis of pro-IL-1b ( Fig. 2b and 2c) . Additionally, effector CD4 T cells were found to constitutively express FasL that was further upregulated upon their interaction with DCs ( Supplementary Fig. 2c ). These observations suggested the possibility that Fas signaling in DCs could be involved in the cleavage of pro-IL-1b. Indeed Fas deficient DCs from lpr mice 28 were unable to secrete cleaved IL-1b underlining the necessity of DC intrinsic Fas signaling in T cell induced IL-1b production ( Fig. 3c  and 3d ). It has been previously shown that Fas signaling in macrophages can trigger cleavage of pro-IL-1b in a caspase-8 dependent manner 29 , however the physiological importance of such IL-1b cleavage is not known. We found that DC-T cell interaction led to maturational cleavage of caspase-8 ( Fig. 3e) . While TNFR signaling has been reported to cause caspase-8 activation 30 , we discovered that only Fas, but not TNFR, signaling is critical for caspase-8 cleavage during cognate DC-T cell interaction (Fig. 3e) . Inhibition of caspase-8 enzymatic activity by IETD resulted in abrogation of IL-1b cleavage implicating caspase-8 as the protease involved in mature IL-1b production by DCs (Fig. 3f ). Caspase-8 has been shown to be important for induction NF-kB dependent genes upon TLR activation, including pro-IL-1b 31, 32 . However, during DC-T cell interactions, caspase-8 inhibition did not affect pro-IL-1b synthesis (Fig. 3f) . Furthermore, genetic deletion of caspase-8, along with RIPK3 to prevent necrosis 33 , in DCs led to a complete loss of secreted IL-1b (Fig. 3g) . Although caspase-8 has been previously implicated in proteolytic cleavage of pro-IL-1b upon TLR4 acitvation 34 , our experiments demonstrate a crucial role for caspase-8 in IL-1b production by DCs in the absence of any PRR activation. Together, these data show that effector CD4 T cells can instruct IL-1b production by DCs thereby revealing a novel PRRindependent mechanism of innate immune activation.
Pathogen sensing by PRRs leads to inflammation primarily caused by secretion of pro-inflammatory cytokines and chemokines from myeloid cells 35 . Our data now suggest that effector CD4 T cells, irrespective of their specificity, could also induce inflammation by eliciting IL-1b production by DCs. Self-reactive CD4 T cells are key players in several IL-1b mediated autoimmune diseases such as RA, type 1 diabetes and multiple sclerosis (MS) [36] [37] [38] . However, whether self reactive CD4 T cells contribute to innate immune pathology by triggering IL-1b production has never been investigated. To test the ability of bona fide self-reactive CD4 T cells to elicit IL-1b production by interacting DCs, we utilized BDC2.5 TCR Tg diabetogenic mice 39 . BDC2.5 CD4 T cells are specific to a known islet cell peptide 40 . We stimulated these CD4 T cells in vitro using autologous DCs in the presence of their cognate peptide. Similar to the in vitro generated effector CD4 T cells, islet cell-reactive T cells also induced IL-1b production by DCs in a FasL and TNFa dependent manner (Fig. 4a ).
Although cytokines made by self-reactive T cells contribute to autoimmune inflammation, innate immune activation is known to be responsible for the precipitation of autoimmunity 41 . The pathology of these diseases is associated with infiltration of neutrophils and inflammatory monocytes into the affected tissues. Since the majority of existing mouse models of T cell driven autoimmunity still rely on initial PRR activation, usually in the form of Mycobacterium tuberculosis, to break tolerance 42 , we employed two new PRR independent approaches to mimic cognate DC-T cell interaction likely to occur during auto-immune flares. In the first approach, we employed in vivo administration of aCD3 speculating that systemic TCR activation would result in widespread T cell reactivation by myeloid cells. Intravenous administration of aCD3 led to rapid transcriptional upregulation of Il1b in the splenocytes (Fig. 4b) . Upregulation of pro-IL-1b protein expression in CD11c+ DCs was also observed upon aCD3 stimulation (Fig. 4c) . Moreover, we saw significant recruitment of neutrophils to the spleen as well as to the small intestinal lamina propria (SI-LP) within 18 hours of stimulation (Fig. 4d) . More importantly, the inflammatory leukocyte recruitment in both the spleen and the SI-LP was significantly dependent on IL-1b (Fig. 4e, 4f and Supplementary Fig. 3a,   b ), establishing that in vivo interactions between T cells and myeloid cells leads to acute IL-1b production, which then promotes inflammatory leukocyte infiltration. In the second approach, we adoptively transferred OT-II TCR Tg Th17 T cells and induced their activation by intravenous administration of the MHCII-restricted OVA peptide (OVA323-339). Based on our in vitro data, we hypothesized that interaction of activated CD4 T cells with DCs bearing cognate peptides in vivo would lead to IL-1b production and result in IL-1b dependent inflammation as measured by expansion of circulating neutrophil populations. In agreement with our hypothesis, we observed that recruitment of neutrophils to the spleens of OT-II T cell receipient mice was dependent on IL-1b (Fig. 4g ). Since we found that Fas signaling in DCs to be the most critical mediator of IL-1b production in vitro, we examined the requirement of Fas for T cell induced inflammation in vivo. We specifically ablated Fas in CD11c expressing cells (Supplementary Fig. 3c ) and investigated its impact on IL-1b mediated leukocyte recruitment following DC-T cell interaction. Fas deletion in DCs significantly inhibited neutrophil infiltration in the SI-LP and spleen (Fig 4h and 4i) thus providing in vivo corroboration of our in vitro findings.
We have previously shown that IL-1b is a critical "licensing signal" for IL-17 production 6 . As we have found an important role for TNFa and Fas in IL-1b production by DCs , we reasoned that TNFR and Fas signaling in DCs may be necessary for cytokine production by Th17 cells during their reactivation. In agreement with our hypothesis, DCs lacking TNFR also had diminished capacity to trigger IL-17 production by effector CD4 T cells (Fig. 4j) . Similarly, we discovered that blocking Fas signaling during T cell reactivation significantly compromised IL17a production (Fig. 4k) . We propose that this novel pathway of IL-1b production, mediated by TNFR and Fas signaling, evolved to enable optimal CD4 T cell effector function. However, cognate interactions of self-reactive effector T cells with antigen presenting myeloid cells are also likely to result in production of bioactive IL-1b, leading to detrimental immunopathology.
Our study thus establishes a previously unknown feature of DC-T cell cross-talk where effector CD4 T cells can instruct the innate immune system to produce IL1b, independent of inflammasome activation. Of note, the signaling requirements of the "T cell instruction", as described here, are parallel to the inflammasome pathway, in that it also relies on two independent signals that govern pro-IL-1b synthesis and its activation by proteolytic cleavage. The distinction between the two mechanisms of IL-1b production can be appreciated with regard to their physiological ramifications. The "TLR-NLR" inflammasome pathway is primarily employed by macrophages, resulting in production of IL-1b that is necessary for clearance of virulent pathogens ( Supplementary Fig. 4 ). In contrast, the T cell instructed IL-1b, made by DCs as a result of TNFR-Fas signaling, is likely to be responsible for auto-immune flares in the absence of any overt pathogenic insult ( Supplementary Fig. 4) . Also, since the quantities of IL-1b produced by DCs are directly dictated by the concentration of the peptide, it is unlikely that bystander or low avidity interaction between DCs and T cells will trigger IL-1b production by DCs. Self-reactive CD4 T cells that escaped thymic selection and underwent effector differentiation perhaps employ this inflammasome-independent pathway of IL-1b production during cognate interaction with DCs, thereby causing innate inflammation associated with autoimmunity. Whether self reactive T cells in fact induce IL-1b in vivo using the "TNFR-Fas" pathway to elicit autoimmunity, requires further testing in T cell dependent autoimmune models.
Aberrant inflammasome activation caused by the gain-of-function mutations in NLRP3 and Pyrin drive IL-1b dependent auto-inflammatory conditions that are also initiated independently of TLRs and other PRRs 14 . The role of inflammasome in T cell driven autoimmune diseases, however, is neither discernible nor established. Strikingly, several lines of evidence support the involvement of TNFR and Fas signaling in autoimmune inflammation. Blocking of TNFa has been shown to effectively inhibit production of IL-1b by human synovial cells 43 . T cell intrinsic deletion of TNFa as well as Fas deficiency attenuates EAE disease severity 44, 45 . Disruption of Fas also prevents autoimmune b cell destruction in non-obese diabetic mouse model 46 . Moreover, single nucleotide polymorphisms have been reported in the Tnfrsf1a, Faslg and Fas loci in strong association with IL-1b mediated autoimmune diseases [47] [48] [49] [50] [51] [52] , thus providing credence to the argument that IL-1b in chronic autoimmune conditions could be dependent on "T cell instruction", rather than inflammasome activation. Our data establishes a novel mechanism of IL-1b production that is initiated by effector CD4 T cells and thus presents an explanation for the presence of IL-1b seen in T cell mediated autoimmunty.
Cell culture Complete RPMI media (RPMI1640 (Hyclone) supplemented with L-glutamine, penicillin-streptomycin, sodium pyruvate, β-mercaptoethanol (Sigma)) was used throughout the experiments.
In vitro differentiation of naïve CD4 T cells: Cell culture treated plates were coated with aCD3 (5μg mL -1 ) and aCD28 (5μg mL -1 ) for 3-4hrs at 37ºC. CD4 + CD62L hi naïve CD4 T cells were isolated from splenocytes using a Mojosort naïve CD4 T cell isolation kit according to manufacturer's protocol. Purified naïve T cells were plated in antibody-coated plates with appropriate polarizing conditions for 5 days. T cell were cultured in complete RPMI supplemented with 10% FCS. Cytokine cocktails for in vitro polarization: Th1 -IL-12 (10ng mL -1 , peprotech), IL-2 (50U mL -1 , peprotech), aIL-4 (10μg mL -1 , Biolegend); Th17 -IL-6 (20ng mL -1 , peprotech), hTGFb (5ng mL -1 , peprotech), aIL-4 (10μg mL -1 , Biolegend), aIFNg (10μg mL -1 , Biolegend), IL-23 (20ng mL -1 , Biolegend) and IL-1b (20ng mL -1 , peprotech), Th2-IL-4 (4ng mL -1 , peprotech), IL-2 (50U mL -1 , Biolegend), and aIFNg (10μg mL -1 , Biolegend), Th0 -IL-2 (50U ml -1 ). For co-culture experiments T cells were rested in 10% RPMI supplemented with IL-2 (10U mL -1 ) for 36hrs before co-culture.
In vitro differentiation of bone marrow derived dendritic cells and retroviral transduction Mouse progenitors were isolated from bone marrow (femurs and tibias). Following RBC lysis, cells were plated at 0.75x10 6 mL -1 in BMDC media (5% FCS containing complete RPMI + 1% rGMCSF (Biolegend, 100ng mL -1 )). Media was replaced on day 2 and day 4 and cells were harvested for experiments on day 5 by gently flushing each well. For retroviral transduction, following RBC lysis cells were plated at 10x10 6 mL -1 in 2mL of retroviral supernatant containing 8µL mL -1 polybrene. Cells were spinfected at 2500 rpm, 32ºC, for 90 minutes, then 3mL of BMDC media was added to each well and cells were incubated overnight. The next morning, ~70% of the media was removed from the wells and spinfection was repeated with fresh retroviral supernatant. On day 5 cells were harvested for experiments.
Co-culture of DC and T cells 1 million DCs were cultured with 4 million T cells in 12 well plate. DC-T cell interaction was triggered by adding either aCD3e (aCD3, 200ng mL -1 ) or OVA323-339 as described in the legends. In experiments measuring secreted IL-1b, IL-1R antagonist (50ng mL -1 ) was added 1hr prior to DC stimulation to block IL-1b consumption. Co-cultures were also pretreated with neutralizing antibodies and inhibitor wherever described. Co-culture experiments were performed in complete RPMI supplemented with 10% FCS. For Western blot analysis of the culture supernatant cells were cultured in 1% FCS containing complete RPMI.
T cell re-stimulation (in vivo) 6-8 weeks old mice were treated with 20μg aCD3 or PBS by i.p. injection. Lamina propria cells and splenocytes were isolated at given time points after stimulation followed by surface and intracellular staining.
Quantitative real-time PCR RNA was isolated using Qiagen RNA extraction kit using manufacturer's protocol. cDNA was synthesized using Random primers and MMLV reverse transcriptase (Invitrogen; 2805-013). The QuantStudio 7 Flex Real-Time PCR System (ThermoFisher Scientific) was used to measure SyBR green (ThermoFisher Scientific) incorporation. All data is normalized to 18s. Laboratory) were used. Anti-β-actin (C4, Santa Cruz, 1:5000) was used as control. Western blot was develop using SuperSignal™ West Pico PLUS Chemiluminescent Substrate (Thermo Fisher) and ECL signal was recorded on X-Ray Films using a developer (Kodak).
Surface and intracellular staining and flow cytometry Cells were stained with relevant antibodies for 30 min on ice and washed. For intracellular staining, Foxp3 staining buffer set (eBioscience; 00-5523-00) was used according to manufacturer's protocol. The stained cells were analyzed with BDLSRII or Novocyte (ACEA biosciences). For cytokine receptor staining, control refers to fluorescence minus one control. Data were analyzed with FlowJo 10 Software.
Isolation of Lamina Propria Lymphocytes
Small intestines were flushed with cold PBS and carefully cut longitudinally. 1-2cm pieces of the tissue were digested twice with 2mM EDTA buffer followed by 3 rounds of enzymatic digestion with Collagenase IV (10 µg/ml, Sigma) and DNase I (500 µg/ml, Sigma). Cell suspensions obtained after digestions were loaded on a 40-70% percoll gradient as described before.
Quantification and statistical analysis Based on previous and preliminary studies in our lab, we predicted that the reported samples sizes would be sufficient to ensure adequate power. Statistical analyses were performed in Prism (Graph pad) using unpaired or paired Student's t test as indicated in the figure legends. Data are presented as means [Symbol] SEM. Significance was considered at *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. n.s. = not significant.
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The data generated during and/or analyzed during the current study are available from the corresponding author on reasonable request. -/-DCs were stimulated with WT Th0 cells using aCD3. Secreted IL-1b was quantified 6h post stimulation (b) WT Th0 effector cells were stimulated with aCD3 and WT DCs in the presence or absence of anti-TNFa (20µg/ml), antiFasL (10µg/ml), and anti-CD40L (20µg/ml), neutralizing antibodies. Secreted IL1b in the culture supernatant was quantified after 6h of culture (c) Whole cell lysates from DCs cultured as indicated with effector CD4 T cells (Th0) in the presence or absence of antibodies were subject to Western blot analysis to detect pro-IL-1b. DCs stimulated with LPS were used as positive control to detect pro-IL1b (d) Effector CD4 T cells (Th0) were stimulated with WT DCs using aCD3 in the presence or absence of anti-TNFa (20ug ml -1 ) neutralizing antibody for 6h. Intracellular pro-IL-1b was quantified using flow cytometry (e) Th0 cells were stimulated with aCD3 using WT DCs in the presence of brefeldin A for 3h. Intracellular TNFa in T cells and DCs was quantified using flow cytometry. 
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